True ovarian volume is underestimated by two-dimensional transvaginal ultrasound measurement

Fertil Steril. 2010 Feb;93(3):995-8. doi: 10.1016/j.fertnstert.2008.10.055. Epub 2008 Dec 23.

Abstract

Objective: To investigate a possible difference between true ovarian volume and ovarian volume estimated with two-dimensional (2D) transvaginal ultrasound.

Design: Prospective clinical and laboratory study.

Setting: University hospital research laboratory.

Patient(s): Premenopausal girls and women from three Danish national fertility centers (A: n = 42; B: n = 6; C: n = 18), who had one entire ovary removed for cryopreservation of ovarian cortex.

Intervention(s): Transvaginal 2D ultrasound measurement of ovarian volume before oophorectomy. True ovarian volume was obtained by weighing the ovary.

Main outcome measure(s): Ovarian volume estimated by weight and ultrasound.

Result(s): Ovarian tissue density was 1.00 g/mL. Mean ovarian volume by ultrasound vs. weight in the three groups was as follows: A: 6.3 mL vs. 7.8 mL; B: 5.4 mL vs. 6.8 mL; and C: 2.8 mL vs. 6.1 ml. Ovarian volume obtained by ultrasound was at least 27% smaller than the true ovarian volume.

Conclusion(s): Ovarian volume was severely underestimated by transvaginal 2D ultrasound measurement.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Anti-Mullerian Hormone
  • Female
  • Humans
  • Immunoglobulin G / adverse effects
  • Infertility, Female / etiology
  • Melphalan / adverse effects
  • Menstrual Cycle
  • Neoplasms / complications
  • Neoplasms / drug therapy
  • Oocytes / cytology
  • Oocytes / diagnostic imaging
  • Ovariectomy*
  • Ovary / cytology*
  • Ovary / diagnostic imaging*
  • Prospective Studies
  • Ultrasonography / methods*
  • Vagina

Substances

  • Immunoglobulin G
  • antineoplastic agent K 18
  • Anti-Mullerian Hormone
  • Melphalan